✦ LIBER ✦

Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance

✍ Scribed by Lewis M. Slater; Sandra L. Murray; Martha W. Wetzel; Paula Sweet; Marie Stupecky

Book ID: 104685414
Publisher: Springer
Year: 1986
Tongue: English
Weight: 493 KB
Volume: 16
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00255285

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclosporin A potentiation of VP-16: pro

Cyclosporin A potentiation of VP-16: production of long-term survival in murine acute lymphatic leukemia

✍ Lewis M. Slater; Jonathan Cho; Martha Wetzel 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 371 KB

VP 16–213 and cyclophosphamide in the tr

VP 16–213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features

✍ Hurd, David D. ;Peterson, Bruce A. ;McKenna, Robert W. ;Bloomfield, Clara D. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

## Abstract The treatment of refractory acute nonlymphocytic leukemia remains a major clinical problem in leukemia therapy. VP 16–213 is an investigational agent that may have specificity for monocytic blasts, and the combination of VP 16–213 and cyclophosphamide is synergistic in experimental leuk

Treatment of refractory acute myeloid le

Treatment of refractory acute myeloid leukemia with mAMSA and VP 16-213 in combination: Results of a clinical phase I/II study

✍ Wolfgang Hiddemann; Dieter Urbanitz; Peter Preusser; Wolf Achterrath; Thomas Büc 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

Twenty patients with refractory AML were treated with mAMSA and VP 16-2 13 in combination to assess the toxicity and anti-leukemic activity of the two-drug regimen. Refractoriness was defined according to the response to induction therapy consisting of 6-thioguanine, cytosine arabinoside and daunoru

CD33-directed therapy with gemtuzumab oz

CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance

✍ Linenberger, M L 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

Pharmacological modification of multi-dr

Pharmacological modification of multi-drug resistance (mdr) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin a and verapamil on mdr leukemia t-cells

✍ Rolf Larsson; Peter Nygren 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 691 KB

A novel fluorometric microculture cytotoxicity assay (FMCA), based on measurements of fluorescein diacetate (FDA) hydrolysis and DNA staining by Hoechst 33342, was used for drug sensitivity testing and detection of resistance reversal in acute lymphoblastic leukemia (ALL) cell lines. The 72-hr assay